Sale!

Sprycel (Dasatinib)

A$0.00

-28%
Sprycel (dasatinib) is a cancer medicine used to treat certain types of leukaemia (including chronic myeloid leukaemia, CML, and Philadelphia chromosome–positive acute lymphoblastic leukaemia, Ph+ ALL). It works by blocking proteins that help cancer cells grow and multiply. Treatment is usually long term and your dose may be adjusted. Take it exactly as directed and keep all appointments for blood tests and monitoring.
Sprycel (Dasatinib) – Patient Information (Australia)

Sprycel (Dasatinib) — Patient-Friendly Medicine Information (Australia)

Sprycel is the brand name for dasatinib, a targeted cancer medicine used to treat certain blood cancers. This guide explains what Sprycel is, how it works, how your body processes it, typical uses, timing, food and medicine interactions, safety considerations, and practical tips for everyday use. It also covers alternative treatment options and Australia-specific availability and guidance.

Important: If you have any questions about your personal situation or how to take Sprycel safely, speak with your treating clinician or pharmacist.

Basic product information

Item Details
Medicine Sprycel (dasatinib)
Medicine type Oral targeted therapy (tyrosine kinase inhibitor, TKI)
How it’s taken By mouth, as tablets once or twice daily depending on regimen
Common formulation Tablets in various strengths (strength depends on prescribed regimen)
Usual handling Swallow whole; do not crush or split unless advised
Availability Typically supplied through Australian channels for eligible patients

What Sprycel is used for (indications)

Sprycel is used to treat specific types of leukaemia and related conditions involving the BCR-ABL and related signalling pathways. It is used when cancer cells carry certain genetic changes that drive abnormal growth.

Common indications include:

  • Chronic Myeloid Leukaemia (CML):
    • Adult and paediatric patients with Philadelphia chromosome–positive CML (Ph+ CML)
    • Use may depend on disease phase and prior treatment history (e.g., in chronic phase, accelerated phase, or blast phase)
  • Philadelphia chromosome–positive Acute Lymphoblastic Leukaemia (Ph+ ALL):
    • Used in selected patients, typically in combination with other therapies depending on age and clinical scenario

The exact suitability of Sprycel depends on your test results and treatment history. Your clinician will decide the most appropriate regimen.

How Sprycel works (mechanism of action)

Sprycel is a tyrosine kinase inhibitor. Many leukaemias depend on abnormal signalling made by specific proteins produced from cancer-related genes. Dasatinib targets these proteins—especially the BCR-ABL tyrosine kinase and related kinases—helping to slow or stop cancer cell growth.

  • Blocks abnormal signalling: By inhibiting the enzymes that drive cell division.
  • Helps control disease: In many patients it reduces disease markers over time and improves clinical outcomes.
  • Targets specific pathways: This is why TKIs are called “targeted” therapies.

Pharmacokinetics (how the body handles dasatinib)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. For dasatinib, key practical points include:

  • Absorption: Dasatinib is absorbed after oral dosing. Food can affect absorption and is discussed below.
  • Distribution: It distributes throughout the body and reaches target tissues.
  • Metabolism: Dasatinib is primarily metabolised by CYP3A4 in the liver. This is one reason interacting medicines (e.g., some antifungals and certain antibiotics) can change its levels.
  • Elimination: It is cleared from the body mainly through metabolism and biliary (bile) pathways.
  • Variability: Blood levels can vary between individuals, which is why monitoring and dose adjustments may be needed.

Typical timing and how to take Sprycel

Sprycel is usually taken , but some regimens may require twice-daily dosing. Follow the schedule given by your clinician.

General timing tips

  • Take it at the same times each day to maintain consistent drug exposure.
  • If you miss a dose:
    • Take it when you remember on the same day if it is close to the scheduled time.
    • If it is close to the next dose, skip the missed dose and continue your normal schedule.
    • Do not take double doses.
  • Keep your routine stable: Try not to frequently change meal timing around doses. If your food routine changes, ask your pharmacist for advice.
  • Swallow whole: Tablets should be swallowed whole with water. Do not crush or split unless specifically instructed.

Food interactions: what to know

Food can affect how much dasatinib your body absorbs. For many patients, the safest approach is to keep a consistent relationship with meals and follow the specific instructions you were given.

Practical guidance:

  • Consistency matters: If you usually take Sprycel with food, continue the same pattern unless your clinician advises changes.
  • Avoid sudden changes: Frequent switching between taking with and without food may change drug exposure.
  • Ask before using antacids: Medications that alter stomach acid (including some antacids and acid reducers) can affect absorption; timing adjustments may be necessary.

Your pharmacist can advise the best schedule for meals and acid-reducing medicines based on your regimen.

Alcohol interactions

Alcohol is not known to directly “cancel out” dasatinib, but alcohol can increase the risk of liver irritation and worsen certain side effects such as fatigue, nausea, dizziness, and dehydration.

  • Use caution: If you drink alcohol, keep it moderate and discuss with your clinician—especially if you have liver function abnormalities.
  • Watch for increased side effects: Stop or reduce alcohol if you notice worsening nausea, dizziness, or sleepiness.
  • Hydration: Maintain good fluid intake, particularly if you experience vomiting or diarrhoea.

Medicine interactions (including OTC and supplements)

Dasatinib levels can be affected by medicines that influence CYP3A4 or those that alter stomach acid. Always tell your healthcare team about all medicines you take, including over-the-counter products and supplements.

Common interaction categories

  • Strong CYP3A4 inhibitors: may increase dasatinib exposure and side effects. Examples (not exhaustive) include some antifungals and certain antivirals.
  • Strong CYP3A4 inducers: may reduce dasatinib exposure and effectiveness. Examples include some medicines for seizures and certain antibiotics (depending on the active ingredient).
  • Acid-reducing medicines: including proton pump inhibitors (PPIs), H2 blockers, and antacids. These may affect absorption; timing adjustments or alternative options may be recommended.
  • Other QT-prolonging medicines: some drugs can affect heart rhythm. Discuss with your clinician if you take medicines known to prolong the QT interval.
  • Blood-thinning medicines (anticoagulants/antiplatelets): There may be an increased bleeding risk if you also have low platelets from cancer or treatment.

Herbal and supplement caution

Some supplements may affect metabolism or bleeding risk. Examples include products containing St John’s wort (often a strong enzyme inducer) or high-dose antioxidant regimens. Check with your pharmacist before starting anything new.

Dosing overview (general information)

Dasatinib dosing depends on the specific diagnosis, age group, disease phase, treatment history, and how you respond to therapy. The actual dose you take should be determined by your clinician.

What typically happens in practice:

  • Starting dose: Based on the indication and regimen.
  • Dose adjustments: May be made if side effects occur or if blood counts or disease markers require changes.
  • Monitoring: Regular blood tests are commonly used to guide ongoing treatment.

Patient-friendly dose-taking tips

  • Use a daily reminder to support adherence.
  • Keep a medication list and bring it to appointments.
  • If you have trouble swallowing tablets, discuss options—do not improvise by crushing unless instructed.

Safety profile: common and serious side effects

Like all medicines, Sprycel can cause side effects. Some are more common; others are less frequent but require urgent attention. Your treating team will monitor you closely, and dose adjustments or supportive treatment may be offered when needed.

Common side effects

  • Fatigue
  • Nausea, vomiting, reduced appetite, or diarrhoea
  • Headache
  • Muscle pain or joint discomfort
  • Skin rash or itching
  • Swelling in some areas of the body (oedema)
  • Changes in blood counts (e.g., lower white blood cells, anaemia, or low platelets)
  • Shortness of breath in some cases

Less common but important risks

  • Fluid-related effects: Some patients may develop fluid accumulation (for example, pleural effusion). Symptoms can include chest tightness, coughing, or breathlessness.
  • Infections: Low white blood cells can increase infection risk.
  • Bleeding: Low platelets increase the risk of bruising or bleeding.
  • Cardiac considerations: Rarely, there may be rhythm-related issues or other cardiac effects. Symptoms to watch include fainting, palpitations, or severe dizziness.
  • Liver and lab changes: Liver enzymes may rise, requiring monitoring and possible dose changes.
  • Severe skin reactions: Seek urgent help for signs of severe rash, blistering, or skin peeling.

When to seek urgent medical help

Contact emergency services or seek urgent medical attention if you experience:

  • Severe trouble breathing, chest pain, or symptoms of significant fluid accumulation
  • Fainting, severe dizziness, or new abnormal heartbeats
  • Uncontrolled bleeding, black/tarry stools, or vomiting blood
  • High fever or signs of infection (especially if you have low white blood cells)
  • Severe allergic reaction (swelling of face/lips, hives, difficulty breathing)

Practical use tips for daily life

Adherence and routine

  • Set alarms for your dosing times.
  • Use a pill organiser only if it does not risk confusion with other medicines; follow pharmacist advice for storage and identification.
  • Keep your medication in its original packaging to help avoid mix-ups.

Monitoring and lab tests

Regular blood tests and disease monitoring are a key part of treatment. Dasatinib can affect blood cell production and organ function. Keeping appointments helps ensure safe dosing and timely adjustments.

Managing nausea and digestive symptoms

  • Small, frequent meals may be easier than large meals.
  • Stay hydrated, particularly if diarrhoea occurs.
  • If nausea is persistent, ask your clinician about anti-nausea options.

Reduce infection risk

  • Report fever or infection symptoms promptly.
  • Maintain good hand hygiene.
  • Avoid contact with people who have contagious illnesses when possible.

Bleeding precautions

  • Use a soft toothbrush and be cautious with shaving if your platelet counts are low.
  • Avoid activities that increase injury risk during periods of low counts.
  • Discuss any procedures or dental work with your clinician.

Alternative options (what else may be considered)

Treatment for Ph+ CML/Ph+ ALL is individualised. Depending on your specific diagnosis, prior treatments, and response, alternative options may include other tyrosine kinase inhibitors or different strategies such as chemotherapy or immunotherapy.

Examples of alternative TKIs (varies by indication and history):

  • Imatinib
  • Nilotinib
  • Bosutinib
  • Ponatinib (for selected high-risk situations)

Your clinician may recommend switching TKIs, adjusting the dose, or combining approaches if disease response is not adequate or if side effects become difficult to manage. In some situations, transplant assessment may be discussed.

Market and legal context for Australia (availability and access)

In Australia, access to specialist cancer medicines such as dasatinib is managed through regulated supply pathways. Availability can depend on:

  • Eligibility for specific medicines through Australian treatment frameworks
  • Clinical criteria and prescriber assessment
  • Hospital and community pharmacy dispensing arrangements
  • Stock availability and logistics

For online pharmacy purchasing and delivery, suppliers generally require that medicines are obtained and dispensed in line with Australian medicines legislation and safety requirements. If you need this medicine, ensure you follow the appropriate pathways provided by your healthcare team.

Recent guidance and updates (how to stay current)

Cancer treatment recommendations can evolve as new research becomes available and as governing bodies update guidance. Recent updates may involve:

  • Refinements to dosing schedules and monitoring
  • New information about side effect management
  • Changes to positioning in treatment pathways (e.g., earlier lines of therapy or specific subgroups)
  • Safety communications regarding particular risks

To stay current, ask your clinician or pharmacist for guidance specific to your diagnosis and the latest local information.

Delivery and availability

We aim to provide timely access while following all required safety and regulatory processes for Australia. Availability may vary by strength and stock levels.

What to expect

  • Verification steps: Suppliers may require confirmation of relevant treatment details before dispensing.
  • Shipping time: Delivery times depend on pharmacy processing time and courier schedules.
  • Cold chain: Dasatinib tablets generally do not require refrigeration; store at room temperature in the original packaging.
  • Returns: Medicines usually cannot be returned once supplied. Check the pharmacy’s policy before ordering.

If you have urgent timing needs, contact customer support to discuss lead times and alternative sourcing options.

FAQ about Sprycel (dasatinib)

1) What is Sprycel used for?

Sprycel (dasatinib) is used for certain blood cancers, particularly Philadelphia chromosome–positive CML and selected cases of Philadelphia chromosome–positive ALL, depending on disease phase and treatment history.

2) How does Sprycel work?

It is a targeted therapy that inhibits tyrosine kinases—most notably BCR-ABL—helping to slow cancer cell growth.

3) When should I take Sprycel?

Many people take it once daily, but some regimens may require twice-daily dosing. Follow the schedule provided by your healthcare team. Take doses at the same times each day for best consistency.

4) Can I take Sprycel with food?

Food can change absorption. Keep a consistent routine and follow any meal-related advice given with your dosing plan. If you use acid-reducing medicines or antacids, ask your pharmacist about timing.

5) What medicines should I avoid?

Because dasatinib is metabolised by CYP3A4, interactions can occur with certain antifungals, antivirals, antibiotics, seizure medicines, and acid-reducing products. Tell your pharmacist about everything you take, including OTC medicines and supplements.

6) Can I drink alcohol while taking Sprycel?

Alcohol may increase side effects and can affect the liver. Keep consumption moderate and discuss with your clinician, especially if your liver tests are abnormal or you have experienced nausea, dizziness, or fatigue.

7) What side effects are most common?

Common side effects include fatigue, nausea, diarrhoea, headaches, and changes in blood counts. Some patients also experience swelling or breathlessness. Report persistent or worsening symptoms.

8) When should I contact a doctor urgently?

Seek urgent medical help for severe shortness of breath, chest pain, fainting, uncontrolled bleeding, black stools, high fever, or signs of a severe allergic reaction.

9) Will my dose be adjusted?

It may be. Dose adjustments are commonly considered based on side effects, blood test results, and how well the medicine controls disease markers.

10) What if I miss a dose?

If you miss a dose, take it when you remember on the same day if it is close to your scheduled time. If it is near the next dose, skip the missed dose and continue as normal. Do not take double doses.

11) Are there alternatives to Sprycel?

Yes. Depending on your diagnosis and response, other TKIs or other treatment strategies may be considered by your clinician.

12) How will I be monitored?

Monitoring typically includes regular blood tests and assessment of disease response. Your clinician may also monitor heart and organ function if needed.

Key takeaways

  • Sprycel (dasatinib) is a targeted oral cancer medicine used for specific Ph+ leukaemias.
  • It works by inhibiting BCR-ABL and related signalling pathways.
  • Drug levels can be affected by food patterns, stomach-acid medicines, and CYP3A4-interacting medications.
  • Side effects can include fatigue, gastrointestinal symptoms, blood count changes, and sometimes fluid-related or breathing symptoms.
  • Regular monitoring and prompt reporting of serious symptoms improve safety.

This information is designed to help you understand Sprycel in everyday terms. It does not replace personalised medical advice. Always consult your healthcare team for guidance tailored to your condition and treatment plan.

Additional information

Dosage: No selection

50mg

Package: No selection

1 bottle, 2 bottle, 3 bottle